Search images on Google Product Monograph
Active Ingredients:
- ranibizumab, 10 MG/ML
DIN: 02542250
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVITREAL
Description: SINGLE USE VIAL
Schedule: Prescription
Company: TEVA CANADA LIMITED – official site
ATC:
- S01 - OPHTHALMOLOGICALS (ATC, WHO, Wiki)
- S01L - OCULAR VASCULAR DISORDER AGENTS (ATC, WHO)
- S01LA - Antineovascularisation agents (ATC, WHO)
- S01LA04 - RANIBIZUMAB (WHO)
Reference brand drug: Lucentis
External Links for Ranopto:
Search on Google
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find ranopto photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.